Study to Investigate the Pharmacokinetic Interaction Between 2 Direct Acting Antiviral Agents Odalasvir and AL-335 and Between 3 Direct Acting Antiviral Agents Simeprevir, Odalasvir and AL-335 at Steady State in Healthy Japanese Participants

Condition:   Healthy
Interventions:   Drug: AL-335;   Drug: Odalasvir (ODV);   Drug: Simeprevir (SMV)
Sponsor:   Janssen Research & Development, LLC
Completed - verified November 2016
Source: 
Study to Investigate the Pharmacokinetic Interaction Between 2 Direct Acting Antiviral Agents Odalasvir and AL-335 and Between 3 Direct Acting Antiviral Agents Simeprevir, Odalasvir and AL-335 at Steady State in Healthy Japanese Participants
News Type: 
Clinical Trials